Document, SOP, assurance and audit groundwork
Your team works from defined quality and product sources, needs traceable drafts or updates and retains assessment and decision.
MEDICAL DEVICES · ORGANISATIONAL FIT
traqx fits controlled quality and documentation work at medical device manufacturers when QMS documents, technical files, SOPs or assurance evidence serve as defined sources for reviewable groundwork. traqx does not replace an eQMS, RIM or design-control system and provides no medical-device or diagnostic function.
THREE CONCRETE SITUATIONS
Each situation shows the controlled input, one agent task, the reviewable result and the manufacturer's boundary.
CONTROLLED INPUTS
Existing QMS procedure, the manufacturer's internal policy, current document template and customer-selected MDR sources.
AGENT TASK
SOP Agent · Compares the procedure with the policy, template and selected sources and prepares a justified update.
REVIEWABLE RESULT
Word file with tracked changes, source and rationale comments, and an updated version history.
HUMAN / SYSTEM BOUNDARY
The manufacturer assesses applicability and regulatory acceptance and releases the document through its own QMS.
CONTROLLED INPUTS
Manufacturer-defined technical documentation package, approved controlled checklist, selected evidence and applicable manufacturer sources.
AGENT TASK
Reviewer Agent · Checks the package against the controlled criteria and separates evidenced coverage from contradictions and gaps.
REVIEWABLE RESULT
Review list with evidenced gaps, contradictions and the affected document passages.
HUMAN / SYSTEM BOUNDARY
The manufacturer decides on completeness, conformity and release; traqx is neither a RIM nor a design-control system.
CONTROLLED INPUTS
Defined use of the production or QMS software, approved user requirements, risk assessment, test records and current trace matrix.
AGENT TASK
Validation Agent · Compares requirements, risks, tests and traces within the documented assurance scope.
REVIEWABLE RESULT
Deltas, a gap list and traceability candidates linked to the provided evidence.
HUMAN / SYSTEM BOUNDARY
The assurance expert defines scope and evidence; FDA CSA is framed only for production and QMS software.
CONTROLLED WORKING MODEL
The concrete manufacturer process determines sources and boundaries; the medical-device label does not create a blanket regulatory assumption.
Technical files, QMS documents, SOPs, templates and applicable external requirements are assigned to the work object.
Result · defined source roomtraqx researches inside the source room and prepares document changes, rationales or traceability suggestions.
Result · reviewable groundworkEvidence passages and open points remain visible; different regulatory contexts are not silently treated as equivalent.
Result · bounded claim scopeQA/RA and subject-matter experts correct, accept or reject. The accountable release path remains in place.
Result · human decisionFIT / BOUNDARY
MDR, FDA CSA and any other applicable context are framed separately for each work object.
OPTIONAL PROCESS EXTENSION: A separately bookable GxP module is only added when a recurring process also needs a preconfigured method, templates, defined work objects and a review path. When a GxP module is added →
Your team works from defined quality and product sources, needs traceable drafts or updates and retains assessment and decision.
traqx does not replace systems of record, control a design-control process or promise a medical-device or diagnostic function.
PRODUCT EVIDENCE, NOT AN INDUSTRY CLAIM
traqx is EU-hosted and works in controlled source rooms; customer documents stay within the agreed tenant and hosting scope and are not used for model training. Experts review and decide. The product dossiers show real system views with synthetic demo data—not medical-device customer outcomes.
Trust Architecture → View product dossiers →VISIBLE PRIMARY SOURCES
Article 10 addresses the general obligations of manufacturers; Annex II addresses technical documentation. The source does not establish an eQMS, RIM or design-control product claim for traqx.
The final FDA guidance addresses software used in production or quality management systems. It is not carried over here to software as a medical device or product functions.
FAQ
traqx fits controlled quality and documentation work at medical device manufacturers when QMS documents, technical files, SOPs or assurance evidence serve as defined sources for reviewable groundwork. traqx does not replace an eQMS, RIM or design-control system and provides no medical-device or diagnostic function.
No. The actual process and applicable regulatory context decide. This page does not equate MDR, FDA CSA and pharmaceutical GMP contexts or infer blanket GxP status from the industry label.
Yes. traqx checks only the package defined by the manufacturer against the approved sources and criteria and makes gaps or contradictions visible. Assessment, the conformity decision and release remain with the manufacturer.
The FDA guidance linked here addresses computer software assurance for software used in production or the quality management system. This page does not extend that scope to software as a medical device or embedded product software.
FRAME THE MEDICAL-DEVICE PROCESS
In the meeting, we define the source room, agent task, review and existing manufacturer-system boundaries for one real process.
Book a meeting →Other industries: All industries · Pharmaceuticals · Biotech · CDMO / CMO · Contract research organizations